European Journal of Clinical Pharmacology 1990-01-01

Excretion of tolbutamide metabolites in young and old subjects.

A K Miller, J Adir, R E Vestal

Index: Eur. J. Clin. Pharmacol. 38(5) , 523-4, (1990)

Full Text: HTML

Abstract

Tolbutamide (1 g/70 kg) was administered as a single intravenous dose to 31 healthy, non-smoking, drug-free males between 23 and 87 years old and the total amounts of hydroxy and carboxytolbutamide excreted in 24 h were measured. There was a significant decrease in the urinary recovery of both metabolites with age. The reason for these findings is not known at the present time and may be associated with the decrease in creatinine clearance observed in these subjects or other changes in the pharmacokinetics of tolbutamide which are currently being investigated.


Related Compounds

Related Articles:

Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.

2008-08-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 871(1) , 78-89, (2008)]

Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.

2004-05-01

[Eur. J. Clin. Pharmacol. 60(3) , 165-71, (2004)]

Quantitative determination of tolbutamide and its metabolites in human plasma and urine by high-performance liquid chromatography and UV detection.

1999-12-01

[Ther. Drug Monit. 21(6) , 664-71, (1999)]

Inhibition of tolbutamide elimination by cimetidine but not ranitidine.

1986-01-01

[J. Clin. Pharmacol. 26(5) , 372-7, (1986)]

Pharmacokinetics of tolbutamide in ethnic Chinese.

1999-02-01

[Br. J. Clin. Pharmacol. 47(2) , 151-6, (1999)]

More Articles...